Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor cell prothrombotic properties.

A Falanga1

  • 1Dept. Hematology-Oncology, Ospedali Riuniti, Bergamo, Italy. annafalanga@yahoo.com

Haemostasis
|May 7, 2002
PubMed
Summary

Cancer patients face higher risks of blood clots due to abnormal thrombin generation and fibrin formation. These processes are also crucial for tumor spread and metastasis, highlighting a complex link between cancer and coagulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical variables associated with late-onset thrombotic and cardiovascular events, after SARS-CoV-2 infection, in a cohort of patients from the first epidemic wave: an 18-month analysis on the "Surviving-COVID" cohort from Bergamo, Italy.

Frontiers in cardiovascular medicine·2023
Same author

Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Lombardy diagnostic and therapeutic network of thrombotic microangiopathy.

Orphanet journal of rare diseases·2022
Same author

Antithrombotic medication in cancer-associated thrombocytopenia: Current evidence and knowledge gaps.

Critical reviews in oncology/hematology·2018
Same author

Polymicrobial antibiofilm activity of the membranotropic peptide gH625 and its analogue.

Microbial pathogenesis·2018
Same author

Comparison Between Folic Acid and gH625 Peptide-Based Functionalization of Fe<sub>3</sub>O<sub>4</sub> Magnetic Nanoparticles for Enhanced Cell Internalization.

Nanoscale research letters·2018

Area of Science:

  • Hematology
  • Oncology
  • Biochemistry

Background:

  • Malignancy is associated with increased risks of thromboembolic complications.
  • Fibrin formation plays a critical role in tumor metastasis.
  • Cancer-associated coagulation activation involves complex interactions between tumor cells and blood components.

Discussion:

  • Tumor cells can directly activate the coagulation cascade by producing procoagulant factors.
  • Tumor cells can enhance the prothrombotic properties of platelets, monocytes, and endothelial cells.
  • The intricate mechanisms of tumor-promoted prothrombotic functions are still under investigation.

Key Insights:

  • Thrombin generation and fibrin formation are significantly altered in cancer patients.
  • Fibrin's role extends beyond hemostasis to encompass tumor progression and metastasis.
  • Tumor cells actively engage with and manipulate the hemostatic system.

Outlook:

  • Further research is needed to fully elucidate the mechanisms of tumor-promoted coagulation.
  • Understanding these interactions may lead to novel therapeutic strategies for cancer-related thrombosis and metastasis.
  • Targeting the pro-thrombotic functions of cancer cells could offer new avenues for treatment.

Related Experiment Videos